Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Sonye K. Danoff et al.|The Lancet Respiratory Medicine|2022Cited by 211
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical StatementAnna J. Podolanczuk, Christopher J. Ryerson, Gary M. Hunninghake et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 78
Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study CohortsBina Choi, Samuel Y. Ash, Alejandro A. Díaz et al.|CHEST Journal|2022Cited by 26
Approach to Clinical Trials for the Prevention of Pulmonary FibrosisJohn S. Kim, Anna J. Podolanczuk, Sydney B. Montesi et al.|Annals of the American Thoracic Society|2023Cited by 10
Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGeneRachel K. Putman, Gary M. Hunninghake, Jonathan A. Rose et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 4